- Home
- VKTX vs PFSI Comparison
VKTX vs PFSI Comparison
Compare VKTX & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKTX | PFSI |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.3B |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VKTX | PFSI |
|---|---|---|
| Price | $34.91 | $84.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $95.86 | ★ $128.11 |
| AVG Volume (30 Days) | ★ 2.2M | 441.9K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | N/A | ★ 59.25 |
| EPS | N/A | ★ 1.53 |
| Revenue | N/A | ★ $984,629,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.96 |
| P/E Ratio | ★ N/A | $55.13 |
| Revenue Growth | N/A | ★ 3.05 |
| 52 Week Low | $22.96 | $77.67 |
| 52 Week High | $43.15 | $160.36 |
Technical Indicators
Market Signals| Indicator | VKTX | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.12 | 53.96 |
| Support Level | $33.65 | $83.93 |
| Resistance Level | $36.77 | $87.40 |
| Average True Range (ATR) | 1.86 | 2.20 |
| MACD | -0.68 | 0.17 |
| Stochastic Oscillator | 5.85 | 72.11 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.